Genome-wide association studies to understand immune diseases
Genetic variants are alternative versions of the DNA sequence that can sometimes be associated with the risk of developing a disease, including autoimmune disorders. Determining the causality between genetic variants and autoimmunity is difficult, due to technical limitations of existing mapping strategies. Blagoje Soskic and collaborators summarise how Genome-wide association studies (GWAS) have contributed to investigating the impact of diverse genetic variants in several autoimmune diseases and discuss both current challenges and future research directions.
Autoimmune disorders – for example, lupus, rheumatoid arthritis, and ulcerative colitis, among others – arise when the immune system attacks bodily tissues and organs. Why the immune system turns against the body remain largely unknown, but host genetics is considered one of the risk factors for autoimmunity. Autoimmune diseases are often determined by variation in the DNA regions controlling function of many genes and are therefore defined as polygenic disorders. In rare cases, mutations in a single gene can also cause an autoimmune disease, which is accordingly called monogenic. GWAS can look at a whole genome of many people at the same time and have been used for the identification of specific DNA variants associated with autoimmune diseases. Furthermore, GWAS have been useful to determine the overall risk of developing a certain autoimmune disease or to respond to a certain drug.
Blagoje Soskic – Research Group Leader at the Human Technopole Genomics Research Centre – and colleagues from the University of Milano-Bicocca, Humanitas University and IRCCS Humanitas Research Hospital, and University of California, Davis, review techniques and approaches that, together with GWAS, allow fine mapping of human genetic variance as well as the identification of genes and cell types involved in immune disorders. The researchers discuss the contribution of exome- and whole-genome sequencing to identify rare variants, and the link between epigenetics and autoimmunity. Finally, Gerusi and Soskic et al. highlight the need for robust statistical and experimental approaches to understand the functions of newly identified genetic variants and their evolutionary history in immune diseases.
The review is published in the Journal of Autoimmunity.
Share:
You could also like:
-
Italy at the centre of the Genome of Europe project
The Human Technopole, ELIXIR Italia, the national node of the European life sciences research infrastructure coordinated by the National Research Council (CNR), and the Centro Cardiologico Monzino, as the Italian coordinating centre, have been selected as the Italian partners of Genome of Europe (GoE), the largest EU-funded genomic project, whose ultimate goal is to make […]
-
Human Technopole wins 2024 Oscar di Bilancio
On Friday 13 December, at Palazzo Mezzanotte in Milan, the Human Technopole Foundation’s ‘Integrated Report 2023’ received the Oscar di Bilancio in the social enterprises and non-profit organisations category. The award was presented to President Gianmario Verona, Elena Trovesi, Head of Administration, as well as the project leaders Giovanni Selmi, Head of Finance, and Alessandro […]
-
Mosaic Organoids to Study the Brains of Multiple Patients Simultaneously
An international team of scientists from Human Technopole and the University of Milan has developed and validated an innovative approach to studying human brain development across multiple individuals simultaneously using single organoids—laboratory models that replicate key cellular processes of human neurodevelopment. The research paves the way for in vitro population studies. Additionally, the scientists have developed a novel computational method to more accurately quantify the genetic identity of individual cells profiled from multiple individuals concurrently. The findings have been published in Nature Methods.
-
Cancer stem cell morphology predicts glioblastoma growth and resistance
Human Technopole researchers have identified adducin-γ (ADD3) as a crucial regulator of glioblastoma cancer stem cell morphology and intercellular bridges between tumour cells. These connections facilitate communication and allow tumour cells to share resources, evade chemotherapy, and survive in challenging conditions. The study has been funded by AIRC and the findings are published in Life Science Alliance.
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.